個案總覽

Supplement case for UV1257.

Supplement case for UV1257.

Supplement case for UV1257.

A short, supplemental case to "The Big Easy, Not So Easy" (208068). Doris Koo must respond to new challenges at Lafitte in New Orleans.

This is a follow-on case to EFI, Inc. (A). It reports on Dean Mills' decision to implement a new compensation approach that pays 25% of salespeople's bonus, based on their individual sales of software add-on products. He also recommends making public each salesperson's performance against their goal in a report that ranked salespeople from top to bottom each period. Students are asked to react to this new plan.

This is a follow-on case to EFI, Inc. (A) and (B). It reports on the sales force's response to the new plan and provides some data as to their performance in the quarters immediately following the implementation of the new plan.

Supplements the Sara Campbell Ltd. (A) case by introducing additional concerns with Holt. In January of 1999, Campbell received a certified letter written by Holt. The letter described Holt's own frustration in working for Campbell. Students are given context to discuss how to proceed.

The communications director of Arla Foods is hoping the decision to denounce to the cartoons will bring an end to the boycott. Instead, it brings complaints from Danish women's groups. This is a supplement to Arla Foods and the Cartoon Crisis (A), Ivey product 9B08M005.

Just as Arla Foods has re-established its reputation in the Middle East, another provocative cartoon is released in a Swedish paper and the communications director of Arla Foods must decide how the company will respond. This is a supplement to Arla Foods and the Cartoon Crisis (A), Ivey product 9B08M005.

The (B) case describes how the various business groups responded to the Chinese government's invitation to submit comments on its draft labor contract law and details the ensuing global controversy. The (B) case also describes changes made to the working draft and provides an overview of the law as finally enacted in June 2007.

In October 2007, the OLPC reported production delays and missed its shipment date. In early November, the $100 PC finally went into production, with initial shipments planned for Uruguay and Mongolia, and mid-month launched the "Give One, Get One" program. It enabled consumers in the U.S. and Canada, who had the option of purchasing an OLPC for $400, more than double the estimated production cost of $188 for each laptop. Roughly half of the $400 amount went towards purchasing an OLPC for the consumer, while the other half went towards financing a laptop for a child in a different country. The program was popular and extended. But just as things were looking up for the non-profit, Intel resigned from OLPC's board in early January 2008 and announced that it would no longer be partnering with the nonprofit corporation. According to Intel, the move was a result of pressure it received from OLPC to stop marketing its own low-cost Windows-based laptop, the Classmate.

To buy a desirable Martha's Vineyard property, Robert and Sally Franklin must craft a bidding strategy informed by their assessment of their competitor. The "A" case sets up the situation and bidding history to date, describes how they assessed their valuations and probabilistic views, and leaves them with a key decision. The B case describes their choice as well as the twists and turns leading to the conclusion.

Supplements the A case [308027]. With its dual listings on the Hong Kong stock market and New York stock Exchange, state-owned enterprise, China Netcom was mandated to meet the listing requirements of these exchanges. From this initial step, China Netcom's Chairman, Zhang Chunjiang, began a program that sought to further develop the company's corporate governance practices to meet international corporate governance standards. The company hoped that its commitment in developing a globally-accepted governance structure would help the capital markets and potential investors understand that the company was true, modern corporation, even with the state as a majority owner.

This five-case series, sold as a package, presents an opportunity for students to understand that leadership mindset is not going from crisis to crisis, but anticipating and shaping your organization. Through four case scenarios, students learn the need to recognize when there is a crisis situation, explore problems that often occur when issues are ignored, and take appropriate actions to remedy the situation. In the (B) case, one month has elapsed since executives at H2O Inc., first learned of an Avian Flu outbreak in China and Indonesia. More cases have surfaced in Europe and now the United States. The leadership team meets to discuss the contents of an e-mail from the plant manager. The team must now prioritize what needs to be done based on the latest challenges.

Supplements with the (A) Case.

This case has been developed to facilitate a negotiation exercise related to the formation of partnership deals in the healthcare industry. It is based on actual information, but reflects a hypothetical situation involving two companies and a product that have all been disguised. The scenario described within the case involves Pharmac, a large pharmaceutical company, and Respire, a small medical start-up. Pharmac and Respire began negotiating a partnership to develop and eventually market an inhaled form of parathyroid hormone (PTH) to treat osteoporosis. If successful, this product would improve the available options for the treatment of osteoporosis. It was also expected to produce "blockbuster" sales since it would make PTH, an already extremely effective treatment option, more convenient and appealing to a large segment of untreated patients who were injection-averse (injection was the standard delivery mechanism for this drug). Development of the product was highly speculative and was expected to take six to seven years due to early stage development of the inhalable delivery system and the multi-year Phase III fracture trials required for approval. Pharmac had released the first man-made, injectable form of parathyroid hormone, called Strocal, in 2002. However, no one had yet developed a non-injectable version of PTH, despite efforts by Pharmac and other companies that spanned more than a decade. Respire's goal was to be the first company to solve this problem by developing an inhaled formulation and a device to deliver Strocal through the lungs in a safe, effective, and reproducible manner. Enough information is provided within the case to enable students to negotiate terms for royalties, milestones, exclusivity provisions, and an equity investment. At the end of OIT-81A, information known to Pharmac (but not to Respire) is provided. In OIT-81B, information known to Respire (but not to Pharmac) is given.

This one-page case, to be handed out in class, briefly lists the three major strategic options facing Uria Menendez.

The Uria Menendez C case describes the passing of the firm's founder, Rodrigo Uria, its continued success (including being one of the Top 10 MNA law firms in the world) and its decision to open an office in Warsaw.

The Uria Menendez (B) Cas describes the three major strategic options facing the firm. It can be used when the instructor wants to teach the case over two classes. The first class, based on the A case, explores the reason for the the firm's success. The B case describes the three main strategic options and the issues regarding each option. In the second class, students can debate each option.